IL95061A0 - Antagonists of gm-csf derived from the carboxyl terminus - Google Patents

Antagonists of gm-csf derived from the carboxyl terminus

Info

Publication number
IL95061A0
IL95061A0 IL95061A IL9506190A IL95061A0 IL 95061 A0 IL95061 A0 IL 95061A0 IL 95061 A IL95061 A IL 95061A IL 9506190 A IL9506190 A IL 9506190A IL 95061 A0 IL95061 A0 IL 95061A0
Authority
IL
Israel
Prior art keywords
antagonists
carboxyl terminus
csf derived
csf
derived
Prior art date
Application number
IL95061A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL95061A0 publication Critical patent/IL95061A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL95061A 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus IL95061A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37984689A 1989-07-14 1989-07-14

Publications (1)

Publication Number Publication Date
IL95061A0 true IL95061A0 (en) 1991-06-10

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95061A IL95061A0 (en) 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus

Country Status (16)

Country Link
US (1) US5475087A (xx)
EP (2) EP0409091A1 (xx)
JP (1) JPH04503815A (xx)
KR (1) KR920701246A (xx)
AU (1) AU630496B2 (xx)
CA (1) CA2062975A1 (xx)
FI (1) FI920150A0 (xx)
HU (1) HUT63181A (xx)
IE (1) IE902562A1 (xx)
IL (1) IL95061A0 (xx)
MY (1) MY105946A (xx)
NO (1) NO920176L (xx)
NZ (1) NZ234479A (xx)
PH (1) PH27534A (xx)
WO (1) WO1991001330A1 (xx)
ZA (1) ZA905480B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (en) * 1991-02-11 1992-08-12 Robert S. Greenfield Gm-csf inhibiting oligopeptides
WO1994011404A1 (en) * 1992-11-19 1994-05-26 Dana-Farber Cancer Institute Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) * 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (en) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition for treating cancer adapted for intra-tumoral administration and uses thereof
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
HUE032584T2 (en) 2006-02-08 2017-09-28 Morphotek Inc Antigen GM-CSF peptides and GM-CSF antibodies
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
EA200900709A1 (ru) * 2006-11-21 2009-12-30 Калобиос Фармасьютикалс, Инк. Способы лечения хронических воспалительных заболеваний с использованием антагониста gm-csf
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
ES2401536T3 (es) 2007-11-13 2013-04-22 Evec Inc. Anticuerpos monoclonales que se unen a HGM-CSF y composiciones medicinales que los comprenden
CN102256621B (zh) * 2008-12-22 2017-12-12 墨尔本大学 疼痛治疗
KR101898982B1 (ko) 2008-12-22 2018-09-14 더 유니버시티 오브 멜버른 골관절염 치료
US9901079B2 (en) 2011-08-18 2018-02-27 New York University Inhibition of oncogenic kras-induced GM-CSF production and function
WO2013072901A2 (en) * 2011-11-17 2013-05-23 Btm Mazowsze Sp. Zo.O. Compositions and methods for treating glioma
EP4291380A1 (en) 2021-02-15 2023-12-20 Splifar S.A. Method for applying a seal to a plate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
EP0188479B1 (en) * 1984-07-06 1991-09-11 Sandoz Ag Lymphokine production and purification
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
AU630496B2 (en) 1992-10-29
HUT63181A (en) 1993-07-28
CA2062975A1 (en) 1991-01-15
AU6148790A (en) 1991-02-22
ZA905480B (en) 1991-03-27
MY105946A (en) 1995-02-28
EP0482086A1 (en) 1992-04-29
NO920176D0 (no) 1992-01-14
PH27534A (en) 1993-08-18
KR920701246A (ko) 1992-08-11
HU9200087D0 (en) 1992-04-28
IE902562A1 (en) 1991-02-27
NZ234479A (en) 1992-03-26
NO920176L (no) 1992-01-14
FI920150A0 (fi) 1992-01-14
JPH04503815A (ja) 1992-07-09
US5475087A (en) 1995-12-12
EP0409091A1 (en) 1991-01-23
WO1991001330A1 (en) 1991-02-07

Similar Documents

Publication Publication Date Title
ZA905480B (en) Antagonists of gm-csf derived from the carboxyl terminus
EP0417959A3 (en) An assembly for locating the position of an object
PH21284A (en) Gnrh antagonists vi
IL65211A0 (en) Polypeptide antagonists arginine vasopressin
GB8917560D0 (en) Coating compositions
EP0502099A4 (en) Chimeric proteins
AU587922B2 (en) Leukotriene antagonists
PT78209A (en) Gnrh antagonists iii
GB8925298D0 (en) Object tracking
AU591459B2 (en) cDNA probe for the detection of bluetongue virus
EP0418863A3 (en) Nmda antagonists
GB8924829D0 (en) Object tracking
ZA84912B (en) Gnrh antagonists
AU1619288A (en) Vasopressin antagonists
GB8923750D0 (en) Sonobuoy location
ZA907896B (en) Substituted acrylamido-penicillanic esters
ZA905205B (en) Theunis christiaan verster the location of objects
IE871656L (en) Leukotriene antagonists
IE872915L (en) Leukotriene antagonists
GB8907660D0 (en) Polypeptide
BG47918A1 (en) Isolated analogous signal adapter
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects
GB8908765D0 (en) The knocker bell
ZA907310B (en) Nmda antagonists
IE871356L (en) Polypeptide compositions